AntimetabolitesAntineoplastic AgentsAntimetabolites, AntineoplasticFloxuridineTetrahydrouridineDrug Screening Assays, AntitumorAntineoplastic Agents, PhytogenicTrabeculectomyFluorouracil6-MercaptopurineLeukemia P388Leukemia L1210Amaryllidaceae AlkaloidsAntibiotics, AntineoplasticMethotrexateEllipticinesNeoplasmsDrug SynergismInosine MonophosphateNarcissusDoxorubicinTumor Cells, CulturedBibenzylsCell SurvivalPhosphoribosyl PyrophosphateMitomycinThiadiazinesAntineoplastic Agents, AlkylatingBryostatinsDrug Evaluation, PreclinicalCytarabineGalliumCell DivisionFolic Acid AntagonistsAncitabineCell CyclePurinesCisplatinDepsipeptidesApoptosisPaclitaxelCell Line, TumorEpothilonesAminoacridinesSarcoma 180Molecular StructureLactonesCell LineAntineoplastic Combined Chemotherapy ProtocolsDeoxycytidineDaunorubicinDose-Response Relationship, DrugKineticsBleomycinDrug Resistance, NeoplasmEtoposideDrug EvaluationXenograft Model Antitumor AssaysProdrugsNeoplasms, ExperimentalMacrolidesDrug ResistanceCell ProliferationHL-60 CellsCamptothecinMice, NudeEnzyme InhibitorsStilbenesLung NeoplasmsPhospholipid EthersNeoplasm TransplantationDrug Administration ScheduleVincristineCyclophosphamideGloves, ProtectiveDNA DamageBreast NeoplasmsDrug InteractionsIsoquinolinesBiotransformationTime FactorsClinical Trials as TopicAster PlantColonic NeoplasmsLeukemiaOvarian NeoplasmsStereoisomerismOccupational ExposureOlacaceaeCaspasesProstatic NeoplasmsTaxoidsMedical SecretariesOncology NursingStructure-Activity RelationshipLaunderingSulindacProtective DevicesDNADental Physiological Processes